Global Biopreservation Market (2020 to 2026) - by Type, Application, End-user, and Geography - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 29, 2020--
The “Biopreservation Market by Type, Application, End-user, and Geography - Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The Biopreservation Market is projected to grow at a rate of 9.2% CAGR by 2026. This research presents a thorough analysis of market share, the present trends, and forthcoming evaluations to explain the approaching investment pockets.
This research provides market insights from 2020 to 2026, which is predicted to allow the shareholders to capitalize on the forthcoming opportunities. The report further offers comprehensive insights into the region, which helps to understand the geographical market and assist in strategic business planning and ascertain future opportunities.
Biopreservation is a process that assists in the conservation of biospecimens such as DNA, saliva, and plasma. This process of biopreservation generally increases the durability, shelf life, and purity of the biosamples. The types of equipment in this process include freezers, liquid nitrogen, consumables, and also media & laboratory information management systems.
This process is also used to preserve food and extend its shelf life, specifically by using lactic acid bacteria. Growth in healthcare spending is assumed for better access to quality healthcare and advanced technology products such as biopreservation facilities, thereby widening the growth expectations. Moreover, the bio-banks, hospitals, and gene banks, which are major end-users for this market, are stimulating the key providers to establish technologically advanced biopreservation products to improve patient outcomes.
In the market for biopreservation, the application of biopreservation consists of therapeutic applications, research applications, clinical trials, and other applications. The biopreservation is primarily applied in therapeutics due to the advancements in regenerative medicine & customized medicine, an increase in the shift of cord blood banking, and the rising incidence of chronic diseases.
The end-users of the biopreservation market include biobanks, gene banks, hospitals, and other end users. The biobanks segment is expected to have a major share in the market. The major share of this segment is attributed to the increasing preference for the preservation of stem cells and the rising numbers of sperm and egg banks.
Further, according to the regional market of biopreservation, the North American region is recorded for the colossal share in the market. This is due to the continuous drug developments and the arrival of advanced therapies in the domain of biomedical research. Additionally, the increasing requirement of expensive and improved treatment for patients’ chronic diseases is the key factor.
The rising incidence of chronic diseases, including cardiac, renal diseases, diabetes, and obesity, is the crucial factor that will propel the biopreservation market growth in the prevailing period. Government initiatives to encourage stem cell therapies to treat the disease, which will again propel market growth. Conversely, the strict regulations for producing biopreservation products and the evolution of room temperature storage procedures may limit the biopreservation market growth.
- Merck KGaA
- Avantor Inc.
- Bio-Techne Corporation
- BioLife Solutions Inc.
- Thermo Fisher Scientific Inc
- ThermoGenesis Holdings Inc.
- Worthington Industries Inc.
- Chart Industries Inc
- So-Low Environmental Equipment Co. Inc.
- Princeton BioCision LLC
- Shanghai Genext Medical Technology Co. Ltd
- Exact Sciences Corporation
- Helmer Scientific Inc.
- CryoTech Inc.
- Nippon Genetics Europe
- PHC Holdings Corporation
- STEMCELL Technologies Inc.
- AMS Biotechnology
- OPS Diagnostics.
Key Topics Covered:
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.8. DRO - Impact Analysis
5. Type: Market Size & Analysis
5.2. Biopreservation Media
5.2.1. Nutrient Media
5.2.3. Growth Factors & Supplements
5.3. Biospecimen Equipment
5.3.1. Temperature Control Systems
5.5. Cryogenic Storage Systems
5.6. Thawing Equipment
5.7.2. Alarms & Monitoring systems
5.7.5. Other Equipment
6. Application: Market Size & Analysis
6.2. Therapeutic Applications
6.3. Research Applications
6.4. Clinical Trials
6.5. Other Applications
7. End User: Market Size & Analysis
7.3. Gene Banks
7.5. Other End Users
8. Geography: Market Size & Analysis
8.2. North America
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
11. Companies to Watch
12. Analyst Opinion
For more information about this report visit https://www.researchandmarkets.com/r/5fplkk
View source version on businesswire.com:https://www.businesswire.com/news/home/20201229005190/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 12/29/2020 06:53 AM/DISC: 12/29/2020 06:53 AM